Research and Study at the University of Excellence in Bonn

The best minds have been able to develop their potential at the University of Excellence in Bonn for over 200 years. Find out more about our strategy in the competition for excellence. Discover our Transdisciplinary Research Areas. Get to know our cross-sectional tasks to improve equal opportunities and sustainability within the scientific community. Welcome to Bonn - welcome to the world.

Latest News

Universities Demand Fair and Responsible AI Development from the G7

The members of the U7+ Alliance of World Universities, which include the University of Bonn, came together for their latest Presidential Summit, entitled “The Role of Universities in Advancing AI.” The network is calling on the G7 to take specific action to enable the whole of society to benefit from artificial intelligence, including supporting universities in AI research, investing in AI training and establishing platforms for North-South collaboration.

Immune Cells Drive Congenital Paralysis Disease

Patients with spastic paraplegia type 15 develop movement disorders during adolescence that may ultimately require the use of a wheelchair. In the early stages of this rare hereditary disease the brain appears to play a major role by over-activating the immune system, as shown by a recent study published in the Journal of Experimental Medicine. The study was led by researchers at the University of Bonn and the German Center for Neurodegenerative Diseases (DZNE). These findings could also be relevant for Alzheimer's disease and other neurodegenerative conditions.

New way to prevent duodenal cancer

People with the hereditary disease familial adenomatous polyposis (FAP) have a greatly increased risk of developing a malignant tumor of the duodenum. Researchers at the University Hospital Bonn (UKB) and the Cluster of Excellence ImmunoSensation2 at the University of Bonn have now discovered a mechanism in the local immune system that can drive the development of cancer. They see this as a promising new approach to preventing duodenal carcinoma in people with FAP. The results have now been published in the journal "Nature Communications".

New Bioactive Compound for Difficult-to-Treat Allergies

Irritable bowel syndrome, chronic itching, asthma and migraine are in many cases hard-to-treat conditions. They have in common that they are triggered by an excessive immune response—which in severe cases can be life-threatening. A team of researchers led by the University of Bonn has now identified a promising bioactive compound that could effectively reduce symptoms and slash fatality risk. The compound blocks a receptor on certain defense cells, thus preventing a derailed immune response. The study findings have been published in the journal Signal Transduction and Targeted Therapy.

All News Items

Events

Tuesday Apr 29, 2025

Globaler Klima- und Umweltwandel – wie wir unsere Natur verändern

Hörsaal II

04:15 PM - 05:45 PM

Aufbauend auf den Ergebnissen des Weltklimarats IPCC und des Weltbiodiversitätsrat IPBES wird beleuchtet, wie wir unsere Natur bereits verändert haben und ...

Tuesday Apr 29, 2025

Labour, Freedom, Slavery - Sociological and Historical Approaches

Niebuhrstr. 5

04:30 PM - 06:00 PM

Join us on April 29th when Theresa Wobbe, BCDSS alumna, will discuss the recently published book “Sklaverei, Freiheit und Arbeit: Soziohistorische Beiträge zur ...

Tuesday Apr 29, 2025

Femtec Career-Building Programme: Info Session

Online

05:00 PM - 06:00 PM

Boost your career as a woman in STEM! In this info session we will introduce the Femtec career-building programme and explain in detail what it offers, how the ...